Healthcare Triangle Announces \$3.96 Million Registered Direct Financing
Healthcare Triangle Secures \$3.96 Million in Registered Direct Offering Priced At-The-Market
Pleasanton, CA, February 26, 2026 – Healthcare Triangle, Inc. (Nasdaq: HCTI), a leader in digital transformation solutions for the healthcare and life sciences sectors, has announced a significant capital raise. The Company has entered into definitive agreements for the sale of approximately \$3.959 million in common stock through a registered direct offering, priced at-the-market under Nasdaq rules.
Key Details of the Financing
-
Offering Structure: Healthcare Triangle will issue 681,553 shares of common stock (or prefunded warrants in lieu thereof), each with a par value of \$0.00001, at a purchase price of \$5.81 per share.
-
Gross Proceeds: The offering is expected to generate gross proceeds of approximately \$3.959 million, prior to the deduction of placement agent fees and other offering expenses.
-
Placement Agent: D. Boral Capital, LLC is acting as the sole placement agent for this transaction.
-
Expected Closing: The offering is anticipated to close on or about February 27, 2026, subject to customary closing conditions.
-
Regulatory Basis: The securities are being offered pursuant to the Company’s shelf registration statement on Form S-3 (File No. 333-276382), which was declared effective by the SEC on January 31, 2024. A prospectus supplement detailing the terms of the offering will be filed with the SEC.
Important Shareholder Considerations
-
Dilution: The issuance of new shares (or prefunded warrants) will increase the total shares outstanding, leading to dilution for existing shareholders. This is a key factor that may impact the Company’s share price in the near term.
-
Use of Proceeds: While the press release mentions the anticipated use of net proceeds, it also contains a forward-looking statement that actual use may differ. Investors should monitor subsequent disclosures for concrete plans on how the new capital will be deployed.
-
Market Impact: The at-the-market pricing and direct offering route can be interpreted as a move to raise capital efficiently, possibly reflecting confidence in the current market valuation but also a need for liquidity.
-
Regulatory and Legal Compliance: The Company highlights that no offer or sale will be made in jurisdictions where it would be unlawful, maintaining compliance with securities regulations.
About Healthcare Triangle
Healthcare Triangle, headquartered in Pleasanton, California, specializes in digital transformation for healthcare providers, payers, and life sciences organizations. The Company leverages advanced technologies and deep industry expertise to drive better health outcomes through improved data and information technology utilization.
Notably, Healthcare Triangle has achieved HITRUST Certification for its Cloud and Data Platform (CaDP), marketed as CloudEz™ and DataEz™. This risk-based, 2-year (r2) Certified status underscores the Company’s commitment to the highest standards of data protection and information security.
Healthcare Triangle supports the adoption of new technologies, data management, business agility, and rapid responses to business needs and competitive threats. The Company is a trusted partner for highly regulated healthcare and life sciences organizations, offering expertise in digital transformation, cloud, security and compliance, data lifecycle management, healthcare interoperability, and clinical and business performance optimization.
Forward-Looking Statements and Risks
Investors should note that this announcement contains forward-looking statements, particularly regarding the intended use of net proceeds from the financing. Actual outcomes may differ due to conditions beyond the Company’s control, including market and regulatory risks. Healthcare Triangle does not undertake to update these statements except as required by law.
For further details, investors are encouraged to review the Company’s filings with the SEC, including the Risk Factors section of the registration statement and related prospectus.
Contact Information
Disclaimer: This article is for informational purposes only and does not constitute an offer to sell or solicitation of an offer to buy any securities. Investors should consult their financial advisors and review regulatory filings before making any investment decisions. The author and publisher do not accept any liability for investment decisions based on this article.
View Healthcare Triangle, Inc. Historical chart here
